Skip to main content
Fig. 4 | Advances in Rheumatology

Fig. 4

From: Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

Fig. 4

Correlation Between Change in Serum Levels of CXCL13 and sICAM-1 and Change in DAS28-ESR at Week 24. CXCL13, C-X-C motif chemokine ligand 13; DAS28-ESR, Disease Activity Score in 28 joints calculated with erythrocyte sedimentation rate; DMARD-IR, inadequate response to disease-modifying antirheumatic drugs; MTX, methotrexate; PBO, placebo; RA, rheumatoid arthritis; sICAM-1, soluble intercellular adhesion molecule-1; TCZ, tocilizumab

Back to article page

Advances in Rheumatology

ISSN: 2523-3106